Eyelashes hypertrichosis: A benign but frequent adverse effect with cetuximab

Autor:	I. Chabbert, H. Fezoui, L. Cals, X. Tchiknavorian, P. Nouyrigat, N. Maille
Rok vydání:	2005
Předmět:	Hypertrichosis Cancer Research medicine.medical_specialty Cetuximab business.industry medicine.drug_class medicine.disease Monoclonal antibody Dermatology digestive system diseases Irinotecan Oncology Medicine business Adverse effect neoplasms medicine.drug
Zdroj:	Journal of Clinical Oncology. 23:3747-3747
ISSN:	1527-7755 0732-183X
Popis:	3747 Background: Cetuximab (ERBITUX) is a monoclonal antibody against R-EGF aproved in Europe since 2004 to use in combination with irinotecan in metastatics colorectal cancers resistant to a irino...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7973d1b763cf8109a891a49c1d6ba967 https://doi.org/10.1200/jco.2005.23.16_suppl.3747 Zobrazit plný text záznamu